Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Gene immunotherapy of colon carcinoma with IL-2 and IL-12 using gene electrotransfer
Authors:ID Komel, Tilen (Author)
ID Omerzel, Maša (Author)
ID Kamenšek, Urška (Author)
ID Žnidar, Katarina (Author)
ID Lampreht Tratar, Urša (Author)
ID Kranjc Brezar, Simona (Author)
ID Dolinar, Klemen (Author)
ID Pirkmajer, Sergej (Author)
ID Serša, Gregor (Author)
ID Čemažar, Maja (Author)
Files:URL URL - Source URL, visit https://www.mdpi.com/1422-0067/24/16/12900
 
.pdf PDF - Presentation file, download (6,92 MB)
MD5: 8C2E5CE838ECAE708FAF67628D645AB9
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Gene immunotherapy has become an important approach in the treatment of cancer. One example is the introduction of genes encoding immunostimulatory cytokines, such as interleukin 2 and interleukin 12, which stimulate immune cells in tumours. The aim of our study was to determine the effects of gene electrotransfer of plasmids encoding interleukin 2 and interleukin 12 individually and in combination in the CT26 murine colon carcinoma cell line in mice. In the in vitro experiment, the pulse protocol that resulted in the highest expression of IL-2 and IL-12 mRNA and proteins was used for the in vivo part. In vivo, tumour growth delay and also complete response were observed in the group treated with the plasmid combination. Compared to the control group, the highest levels of various immunostimulatory cytokines and increased immune infiltration were observed in the combination group. Long-term anti-tumour immunity was observed in the combination group after tumour re-challenge. In conclusion, our combination therapy efficiently eradicated CT26 colon carcinoma in mice and also generated strong anti-tumour immune memory.
Keywords:colon carcinoma, gene electrotransfer, gene immunotherapy
Publication status:Published
Publication version:Version of Record
Submitted for review:20.07.2023
Article acceptance date:15.08.2023
Publication date:17.08.2023
Publisher:MDPI
Year of publishing:2023
Number of pages:str. 12900-1-12900-25
Numbering:Vol. 24, no. 16
Source:Basel, Switzerland
PID:20.500.12556/DiRROS-18508 New window
UDC:602.6/.7
ISSN on article:1422-0067
DOI:10.3390/ijms241612900 New window
COBISS.SI-ID:162334211 New window
Copyright:by Authors
Note:Nasl. z nasl. zaslona; Opis vira z dne 25. 8. 2023;
Publication date in DiRROS:21.03.2024
Views:116
Downloads:55
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 New window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:17.08.2023

Secondary language

Language:Slovenian
Keywords:rak debelega črevesa, elektroprenos genov, genska imunoterapija


Back